VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 2 filers reported holding VECTIVBIO HLDG AG in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $357,745 | -99.0% | 21,206 | -99.5% | 0.00% | -100.0% |
| Q1 2023 | $34,120,818 | -0.1% | 3,967,537 | -0.0% | 0.01% | 0.0% |
| Q4 2022 | $34,163,060 | +81.0% | 3,967,835 | +26.2% | 0.01% | +100.0% |
| Q3 2022 | $18,871,000 | +11.2% | 3,145,251 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $16,973,000 | +32.6% | 3,143,237 | +15.4% | 0.00% | +33.3% |
| Q1 2022 | $12,797,000 | -4.2% | 2,722,646 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $13,359,000 | -35.6% | 2,720,816 | -0.0% | 0.00% | -25.0% |
| Q3 2021 | $20,734,000 | -33.6% | 2,721,363 | -0.2% | 0.00% | -42.9% |
| Q2 2021 | $31,235,000 | – | 2,725,767 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,084,310 | $14,527,000 | 6.18% |
| Novo Holdings A/S | 3,380,402 | $15,922,000 | 0.84% |
| Cormorant Asset Management, LP | 2,078,485 | $9,790,000 | 0.75% |
| Orbimed Advisors | 5,330,704 | $25,108,000 | 0.41% |
| Bpifrance SA | 2,806,217 | $13,217,000 | 0.37% |
| Eventide Asset Management | 2,339,044 | $10,994,000 | 0.17% |
| Tekla Capital Management LLC | 756,502 | $3,556,000 | 0.12% |
| Canaan Partners XI LLC | 37,051 | $175,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 393,365 | $1,849,000 | 0.02% |
| Citadel Advisors | 2,722,646 | $12,797,000 | 0.00% |